Valacyclovir is highly effective at treating herpes simplex virus (HSV-1 and HSV-2) and varicella-zoster virus (shingles), though “effective” means different things depending on the condition. It shortens outbreaks by roughly one to two days, reduces viral shedding by over 90%, and when taken daily, keeps most people outbreak-free for extended periods. It does not cure any of these viruses, but it is one of the most reliable tools for managing them.
How Valacyclovir Works
Valacyclovir is a prodrug, meaning your body converts it into its active form, acyclovir, almost immediately after you swallow it. The conversion happens in your gut and liver during absorption. What makes valacyclovir preferable to taking acyclovir directly is bioavailability: your body absorbs about 54% of the active drug from valacyclovir, which is three to five times more than what you’d get from an equivalent oral dose of acyclovir. That means fewer pills per day for the same effect.
Once converted, the drug works by hijacking a process the virus needs to replicate. Herpes viruses produce a specific enzyme when they infect a cell, and acyclovir exploits that enzyme to get activated. The activated drug then inserts itself into the virus’s growing DNA strand, stops the chain from extending, and shuts down the enzyme responsible for copying viral DNA. Because healthy cells don’t produce this viral enzyme, the drug is highly selective. It targets infected cells and largely leaves everything else alone.
Cold Sores (HSV-1)
For cold sores, valacyclovir works best as a short, aggressive course taken at the very first sign of an outbreak, ideally during the tingling or burning sensation before a blister appears. Two large placebo-controlled studies found that a single day of high-dose treatment reduced the total duration of a cold sore episode by about one day. That translates to roughly an 18 to 21% reduction in healing time for blisters that do develop.
One day faster may not sound dramatic, but cold sore outbreaks typically last only five to six days, so shaving a full day off is meaningful. Pain and discomfort also resolved significantly faster compared to placebo. The key limitation is timing: the closer to the first symptom you start, the better your results. Some people who treat early enough prevent the blister from fully forming at all.
Genital Herpes: Outbreak Treatment
For a first episode of genital herpes, valacyclovir is taken twice daily for 10 days. First episodes tend to be the most severe, with more extensive sores and systemic symptoms like fever, and antiviral treatment during this window significantly reduces the duration and intensity of the outbreak.
For recurrent episodes, the treatment window is shorter: twice daily for just three days. The CDC notes that episodic treatment is most effective when started within one day of lesion onset or during the prodrome stage. Valacyclovir, acyclovir, and famciclovir all appear equally effective for treating recurrent genital herpes outbreaks, so the choice between them often comes down to dosing convenience. Valacyclovir’s higher bioavailability means you take fewer pills less often.
Daily Suppressive Therapy
For people who experience frequent outbreaks, taking valacyclovir every day rather than waiting for symptoms can dramatically reduce recurrence. The standard suppressive dose is once daily, and this approach both prevents outbreaks and reduces the risk of transmitting the virus to a partner.
One of the most striking findings supporting suppressive therapy comes from viral shedding data. In one study, the rate of detectable viral shedding on the skin dropped from 9.7% of days before suppression to just 0.05% of days during daily valacyclovir use. That’s a 94% reduction in the days the virus was actively present on the skin surface. Since transmission is driven by shedding, whether or not symptoms are visible, this reduction matters both for outbreak prevention and partner protection.
Suppressive therapy is typically reassessed after about a year. Many people find their outbreak frequency decreases naturally over time, and some are able to stop daily treatment or switch to episodic treatment as needed.
Shingles (Herpes Zoster)
For shingles, valacyclovir is taken three times daily for seven days, ideally started within 72 hours of the rash appearing. The primary goal is to shorten the acute illness, but the bigger concern for most patients is postherpetic neuralgia, the nerve pain that can linger for months after the rash heals.
In clinical trials, about 20% of patients treated with valacyclovir still developed postherpetic neuralgia at the 90-day mark, and the median time to pain resolution was roughly 29 days. About 75% of patients on valacyclovir achieved permanent resolution of their shingles-related pain. These numbers are consistent with what earlier published reports have found, confirming that while valacyclovir helps, it doesn’t eliminate the risk of lingering nerve pain entirely, especially in older adults.
Side Effects and Safety
Valacyclovir is well tolerated. Side effects occur at rates similar to placebo in clinical trials, which means most of what people experience while taking it (headache, nausea, mild stomach discomfort) happens at the same rate whether or not they’re actually taking the drug. These are the most commonly reported issues, and they’re generally mild.
Long-term daily use for suppressive therapy carries a similar safety profile. The drug has been used at suppressive doses for years at a time without significant accumulation of side effects, which is one reason it’s a go-to option for people managing frequent recurrences.
Drug Resistance
Resistance to acyclovir-based drugs, including valacyclovir, is rare in people with healthy immune systems. Resistant strains of herpes simplex virus are found in less than 1% of the general population, regardless of how long someone has been taking the medication. Resistance is more of a concern in immunocompromised individuals, such as organ transplant recipients or people with advanced HIV, where resistant strains can emerge after prolonged or repeated treatment courses.
How Quickly It Starts Working
After you take a dose, valacyclovir is absorbed and converted to its active form rapidly. The prodrug itself is essentially undetectable in the blood within three hours because the conversion is so efficient. Peak levels of the active drug are reached quickly, and the therapeutic effect begins with the first dose. For cold sores, the entire treatment course is just one day. For genital herpes outbreaks, most people notice reduced symptoms within the first day or two of starting treatment, though the full course should always be completed.